guselkumab
New AGA Living Guideline Expands Recommended Drugs for Moderate to Severe UC
The AGA has released a new, updated guideline on pharmacologic management of adult outpatients with ulcerative ...
NOVEMBER 26, 2024
Miguel Regueiro, MD, Picks His Favorite IBD Research From ACG 2024
Miguel Regueiro, MD, sat down with GEN to talk about some of his favorite studies focused on treating IBD.
NOVEMBER 19, 2024
Guselkumab Shows Maintenance Efficacy in Initial Induction Nonresponders
New data has found guselkumab can be successful as a maintenance therapy even in those who initially did not ...
OCTOBER 27, 2024
FDA Approves Guselkumab for UC
The FDA has approved guselkumab (Tremfya, Janssen) for patients with moderately to severely active ulcerative ...
SEPTEMBER 12, 2024
Combination Advanced Therapy in the Treatment of Inflammatory Bowel Disease
The development of effective biologics and small molecule targeted therapies has revolutionized the treatment of ...
SEPTEMBER 5, 2024
Guselkumab Shows Promise In Crohn’s Disease Trials
Guselkumab induced higher levels of clinical and endoscopic remission than placebo and ustekinumab in the GALAXI ...
AUGUST 23, 2024
Expert Picks From DDW 2024, Part 1: IBD, EoE, NERD and More
In this installment of Expert Picks from DDW 2024, Anisa Shaker, MD, discusses five of her favorite abstracts and ...
JULY 12, 2024
Miguel Regueiro, MD, Picks His Favorite IBD Research From DDW 2024
Digestive Disease Week 2024 was overflowing with research on all GI topics.
MAY 30, 2024
Herbal Treatments for Active UC; Guselkumab for Active Crohn’s
This month’s report highlights two studies: two herbal compounds for the treatment of UC and the guselkumab ...
MAY 14, 2024
QUASAR Study on Potential UC Treatment; COVID-19 Vaccine Not Associated With IBD Flares
In The Regueiro Report this month, I examine two hot topics in our field—about potential new treatments or ...
APRIL 11, 2024
Anti–IL-23 Agents Effective After Prior UC Treatment Failure
VANCOUVER, B.C.—Two different monoclonal antibodies targeting the interleukin-23 p19 subunit achieved all of ...
JANUARY 22, 2024
Advanced Therapy Combinations Show Promise in Treatment of IBD
Therapeutic strategies employing a combination of advanced therapies are starting to reveal promising outcomes in ...
JANUARY 15, 2024
